Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion description "[In addition, we summarize relevant patents on RhoA/Rho kinase and p21-activated kinase as targets of anti-cancer therapy and discuss the clinical potential of different approaches to modulate RhoA/Rho kinase and p21-activated kinase signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion evidence source_evidence_literature NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion SIO_000772 19519534 NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion wasDerivedFrom befree-20140225 NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_assertion wasGeneratedBy ECO_0000203 NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.
- befree-20140225 importedOn "2014-02-25" NP766447.RAsxlRvn-WU1dLOG1HoTpa1mua1w8lSBQWZciCRH1TY3Y130_provenance.